LOX and breast carcinoma: Three-aminopropionitrile (βAPN), an inhibitor of all five lysyl oxidase family members, was used to treat established tumors in five different syngeneic models, 4T1, EMT6 and E0771 breast carcinomas, Lewis lung carcinomas (LLC), and MT6 fibrosarcomas.